| Literature DB >> 25968175 |
Anika Hüsing1, Laure Dossus2,3,4, Pietro Ferrari5, Anne Tjønneland6, Louise Hansen6, Guy Fagherazzi2,3,4, Laura Baglietto7,8, Helena Schock9, Jenny Chang-Claude10, Heiner Boeing11, Annika Steffen11, Antonia Trichopoulou12,13, Christina Bamia14, Michalis Katsoulis12, Vittorio Krogh15, Domenico Palli16, Salvatore Panico17, N Charlotte Onland-Moret18,19, Petra H Peeters18,19, H Bas Bueno-de-Mesquita19,20,21, Elisabete Weiderpass22,23,24,25, Inger T Gram22, Eva Ardanaz26,27, Mireia Obón-Santacana28, Carmen Navarro27,29,30, Emilio Sánchez-Cantalejo27,31, Nerea Etxezarreta27,32, Naomi E Allen33, Kay Tee Khaw34, Nick Wareham35, Sabina Rinaldi5, Isabelle Romieu5, Melissa A Merritt19, Marc Gunter19, Elio Riboli19, Rudolf Kaaks9.
Abstract
Endometrial cancer (EC) is the fourth most frequent cancer in women in Europe, and as its incidence is increasing, prevention strategies gain further pertinence. Risk prediction models can be a useful tool for identifying women likely to benefit from targeted prevention measures. On the basis of data from 201,811 women (mostly aged 30-65 years) including 855 incident EC cases from eight countries in the European Prospective Investigation into Cancer and Nutrition cohort, a model to predict EC was developed. A step-wise model selection process was used to select confirmed predictive epidemiologic risk factors. Piece-wise constant hazard rates in 5-year age-intervals were estimated in a cause-specific competing risks model, five-fold-cross-validation was applied for internal validation. Risk factors included in the risk prediction model were body-mass index (BMI), menopausal status, age at menarche and at menopause, oral contraceptive use, overall and by different BMI categories and overall duration of use, parity, age at first full-term pregnancy, duration of menopausal hormone therapy and smoking status (specific for pre, peri- and post-menopausal women). These variables improved the discriminating capacity to predict risk over 5 years from 71% for a model based on age alone to 77% (overall C statistic), and the model was well-calibrated (ratio of expected to observed cases = 0.99). Our model could be used for the identification of women at increased risk of EC in Western Europe. To achieve an EC-risk model with general validity, a large-scale cohort-consortium approach would be needed to assess and adjust for population variation.Entities:
Keywords: Endometrial cancer; Epidemiology; Prevention; Risk model
Mesh:
Year: 2015 PMID: 25968175 DOI: 10.1007/s10654-015-0030-9
Source DB: PubMed Journal: Eur J Epidemiol ISSN: 0393-2990 Impact factor: 8.082